ArticleLife sciences2016

Linagliptin attenuates diabetes-induced cerebral pathological neovascularization in a blood glucose-independent manner: Potential role of ET-1.

Mohammed Abdelsaid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.